The market for weight loss drugs is white-hot, and competition is heating up fast. This Danish company is already facing a ...

Here is my list of three expert market predictions for May 2025, including insights on yields and job market trends. Read ...

Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following ...

Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...

Viking Therapeutics (VKTX) stock rises as Pfizer (PFE) plans to bolster its pipeline with cardiometabolic and other obesity drugs, through acquisitions. Read more here.

Fintel reports that on April 28, 2025, Cantor Fitzgerald initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a ...

The theory goes like this: Lee cut his price target on Viking from $95 to $75 a share, warning the company faces "intensifying competition in the obesity space" (as The Fly reports today). Yet even so ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

CompanyOverview\|NASDAQ:VKTX] Viking Therapeutics Inc. (NASDAQ: VKTX)reported earnings after the market closed on Apr. 23.

Viking Therapeutics (NasdaqCM:VKTX) reported a quarterly net loss of $45.63 million for Q1 2025, up from $27.36 million in the previous year, pushing the stock up 7.7% over the last week. Despite the ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGEN – Research Report) and Viking Therapeutics ...

In a report released today, George Farmer from Scotiabank reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report), with a price ...